Treace Medical Concepts Inc (TMCI) gains 1.80% for July 21

Equities Staff  |

Treace Medical Concepts Inc (NASDAQ: TMCI) shares gained 1.80%, or $0.5 per share, to close Wednesday at $28.24. After opening the day at $27.90, shares of Treace Medical Concepts fluctuated between $29.75 and $27.71. 345,969 shares traded hands an increase from their 30 day average of 313,612. Wednesday's activity brought Treace Medical Concepts’s market cap to $1,489,663,248.

About Treace Medical Concepts Inc

Based in Ponte Vedra, FL, Treace Medical Concepts, Inc. is a privately-held medical device company focused on advancing the standard of care for the surgical management of bunion deformities. The Company’s patented Lapiplasty® 3D Bunion Correction™ system is designed to reproducibly correct all three planes of the bunion deformity and address the root cause of the bunion, while allowing patients to get back to their active lives quickly.

Visit Treace Medical Concepts Inc’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on Treace Medical Concepts Inc and to follow the company’s latest updates, you can visit the company’s profile page here: Treace Medical Concepts Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Market Movers

Sponsored Financial Content